RB1 and cancer: Accordingly, inhibition of cyclin D-CDK4/6 kinase in RB-proficient cancer cells causes cell cycle arrest and/or senescence23,24, whereas, RB-deficient cancer cells do not halt their proliferation upon CDK4/6 inhibition21,23,25.